Literature DB >> 16052296

Endothelial function in patients with sickle cell anemia during and after sickle cell crises.

Arnon Blum1, Shay Yeganeh, Aviva Peleg, Fina Vigder, Konstantin Kryuger, Ahmed Khatib, Khalid Khazim, Harold Dauerman.   

Abstract

BACKGROUND: Prior studies have demonstrated increased adherence of sickle cell erythrocytes to vascular endothelial cells. While decreased production of nitric oxide and increased production of adhesion molecules have been implicated in this pathophysiology, the relative contribution of these mechanisms during acute sickle cell crises as compared to steady state conditions have not been elucidated. METHODS AND
RESULTS: We studied 10 consecutive young adult patients presenting with a sickle cell crisis. Endothelial function was evaluated by a non-invasive brachial artery shear stress method. Serum levels of adhesion molecules were obtained during the crisis. Both brachial artery responsiveness and serum levels of adhesion molecules were then repeated at steady state. Ten age and gender matched volunteers served as a control group. Impaired endothelial function and impaired endothelium-independent vasodilatation were observed in all sickle cell patients during both steady state and during crisis. Flow mediated dilation (FMD)% was 3.25+/- 2.76% during crisis, 4.57+/- 4.11 at steady state, compared with the control group FMD of 11.64+/- 7.69% (p< 0.001). Flow independent dilation was 10.35+/- 11.3% during crisis, 10.03+/- 6.52% at steady state, compared with control group FID of 24.17+/- 11.87% (p< 0.001). Levels of cell adhesion molecules and markers of inflammation were increased in sickle cell crisis patients compared with the control group: sCD40 ligand levels during the acute crisis were over twice the level of normal matched volunteers (p=0.02), and similarly significant increases were seen for E-selectin (p=0.008), ICAM-1 (p=0.037) and VCAM-1 levels (p=0.01). The levels of each of these biomarkers was not significantly increased during acute crises as compared to patients' recovery state.
CONCLUSIONS: Sickle cell anemia patients have severe systemic endothelial dysfunction as demonstrated by both brachial artery assessment and increased serum levels of adhesion molecules. These abnormalities characterize not only the sickle cell crisis but also the steady state pathophysiology of sickle cell anemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052296     DOI: 10.1007/s11239-005-1377-7

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  11 in total

Review 1.  Sickle cell vaso-occlusion: multistep and multicellular paradigm.

Authors:  Paul S Frenette
Journal:  Curr Opin Hematol       Date:  2002-03       Impact factor: 3.284

2.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation.

Authors:  L Belhassen; G Pelle; S Sediame; D Bachir; C Carville; C Bucherer; C Lacombe; F Galacteros; S Adnot
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

4.  Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.

Authors:  C R Morris; F A Kuypers; S Larkin; E P Vichinsky; L A Styles
Journal:  J Pediatr Hematol Oncol       Date:  2000 Nov-Dec       Impact factor: 1.289

5.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

6.  Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.

Authors:  J D Belcher; P H Marker; J P Weber; R P Hebbel; G M Vercellotti
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

7.  Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis.

Authors:  A J Duits; R C Pieters; A W Saleh; E van Rosmalen; H Katerberg; K Berend; R A Rojer
Journal:  Clin Immunol Immunopathol       Date:  1996-10

8.  Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Authors:  Mark T Gladwin; Alan N Schechter; Frederick P Ognibene; Wynona A Coles; Christopher D Reiter; William H Schenke; Gyorgy Csako; Myron A Waclawiw; Julio A Panza; Richard O Cannon
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

9.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  16 in total

1.  The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Authors:  Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

2.  Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.

Authors:  Emmanuil S Hatzipantelis; Zoe Dorothea Pana; N Gombakis; A Taparkou; V Tzimouli; D Kleta; D J Zafeiriou; V Garipidou; F Kanakoudi; M Athanassiou
Journal:  Int J Hematol       Date:  2013-06-27       Impact factor: 2.490

Review 3.  Placental growth factor: What hematologists need to know.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Blood Rev       Date:  2016-08-27       Impact factor: 8.250

4.  Elimination of the fibrinogen integrin αMβ2-binding motif improves renal pathology in mice with sickle cell anemia.

Authors:  Md Nasimuzzaman; Paritha I Arumugam; Eric S Mullins; Jeanne M James; Katherine VandenHeuvel; Marilou G Narciso; Maureen A Shaw; Sarah McGraw; Bruce J Aronow; Punam Malik
Journal:  Blood Adv       Date:  2019-05-14

5.  Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.

Authors:  Jeanne E Hendrickson; Eldad A Hod; Jennifer R Perry; Samit Ghosh; Prasanthi Chappa; Olufolake Adisa; Leslie S Kean; Solomon F Ofori-Acquah; David R Archer; Steven L Spitalnik; James C Zimring
Journal:  Transfusion       Date:  2011-07-25       Impact factor: 3.157

6.  Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

Authors:  Roberto F Machado; A Kyle Mack; Sabrina Martyr; Christopher Barnett; Peter Macarthur; Vandana Sachdev; Inez Ernst; Lori A Hunter; Wynona A Coles; James P Nichols; Gregory J Kato; Mark T Gladwin
Journal:  Br J Haematol       Date:  2006-12-08       Impact factor: 6.998

7.  Sickle cell microvascular paradox-oxygen supply-demand mismatch.

Authors:  Jon A Detterich; Roberta Kato; Adam Bush; Patjanaporn Chalacheva; Derek Ponce; Madushka De Zoysa; Payal Shah; Michael C Khoo; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2019-04-19       Impact factor: 10.047

8.  Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.

Authors:  Paritha I Arumugam; Eric S Mullins; Shiva Kumar Shanmukhappa; Brett P Monia; Anastacia Loberg; Maureen A Shaw; Tilat Rizvi; Janaka Wansapura; Jay L Degen; Punam Malik
Journal:  Blood       Date:  2015-08-18       Impact factor: 22.113

9.  Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia.

Authors:  Veerapol Kukongviriyapan; Nuntiya Somparn; Laddawan Senggunprai; Auemduan Prawan; Upa Kukongviriyapan; Arunee Jetsrisuparb
Journal:  Pediatr Cardiol       Date:  2007-09-22       Impact factor: 1.655

10.  The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia.

Authors:  Robert I Liem; Kasiemobi Onyejekwe; Marie Olszewski; Chisalu Nchekwube; Frank P Zaldivar; Shlomit Radom-Aizik; Mark J Rodeghier; Alexis A Thompson
Journal:  Br J Haematol       Date:  2015-10-12       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.